RENX Insider Trading

Insider Ownership Percentage: 35.74%
Insider Buying (Last 12 Months): £6,514
Insider Selling (Last 12 Months): £6,695.68

Renalytix Insider Trading History Chart

This chart shows the insider buying and selling history at Renalytix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Renalytix Share Price & Price History

Current Price: GBX 9.22
Price Change: Price Increase of +0.22 (2.44%)
As of 03/25/2025 12:26 PM ET

This chart shows the closing price history over time for RENX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Renalytix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/10/2024James Renwick McCulloughInsiderBuy25,000GBX 9£2,250
12/5/2024James Renwick McCulloughInsiderBuy53,300GBX 8£4,264
10/7/2024Christopher H B MillsInsiderSell83,696GBX 8£6,695.68
See Full Table

SEC Filings (Institutional Ownership Changes) for Renalytix (LON:RENX)

28.35% of Renalytix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Renalytix logo
Renalytix (LSE: RENX) (NASDAQ: RNLX) is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company’s lead product is KidneyIntelX, which has been granted Breakthrough Designation by the U.S. Food and Drug Administration and which is being designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery (visit www.kidneyintelx.com). For more information, visit www.renalytix.com.
Read More on Renalytix

Today's Range

Now: GBX 9.22
Low: 8.89
High: 9.29

50 Day Range

MA: GBX 10.33
Low: 8.50
High: 12.35

52 Week Range

Now: GBX 9.22
Low: 6.50
High: 36

Volume

55,615 shs

Average Volume

262,143 shs

Market Capitalization

£38.22 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.1

Who are the company insiders with the largest holdings of Renalytix?

Renalytix's top insider investors include:
  1. Christopher H B Mills (Insider)
  2. James Renwick McCullough (Insider)
Learn More about top insider investors at Renalytix.